|
⚲
|
| Keyboard |
| Douglas Carnes | |
|---|---|
| Firm | |
| Address | c/o Blinktbi, Inc 635 Rutledge Avenue, Suite 106 Charleston, SC 29403 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Kerdea Technologies Inc | 021-366329 | Executive Officer | 0.1 M of 0.1 M |
||
| Blinktbi Inc | 021-359453 | Executive Officer | 6.0 M of 7.9 M |
||
| Blinktbi Inc | 021-327220 | Executive Officer | 0.7 M of 1.5 M |
||
| Blinktbi Inc | 021-296803 | Executive Officer | 0.8 M of 4.4 M |
||
| Kerdea Technologies Inc | 021-263128 | Executive Officer | 0.8 M of 1.2 M |
||
| Perle Bioscience Inc | 021-252501 | Director | 1.8 M of 2.8 M |
||
| Kerdea Technologies Inc | 021-225309 | Executive Officer | 0.5 M of 0.8 M |
||
| Kerdea Technologies Inc | 021-195971 | Executive Officer | 1.7 M of 1.7 M |
||
| Minivax Inc | 021-195920 | Executive Officer | 0.1 M of 1.5 M |
||
| Immunologix Inc | 021-163167 | Executive Officer | 0.3 M of 1.1 M |
||
| Immunologix Inc | 021-140126 | Executive Officer | 1.1 M of 1.2 M |
||